What is Canary Speech?
Headquartered in Utah, Canary Speech operates as the global leader in speech-based digital biomarkers. The company's patented technology facilitates real-time vocal analysis using standard smart devices, requiring as little as 20 seconds of audio to generate actionable health data. This innovation is specifically engineered to serve the hospital, health and wellness, and pharmaceutical sectors. By integrating its AI-driven platform into telemedicine and remote monitoring workflows, Canary Speech is actively transforming how healthcare providers assess patient outcomes, improve quality of life, and streamline clinical decision-making processes. The company's trajectory reflects a shift toward non-invasive, scalable diagnostic tools that prioritize patient-centric care models.
How much funding has Canary Speech raised?
Canary Speech has raised a total of $13.1M across 2 funding rounds:
Debt
$120K
Series A
$13M
Debt (2021): $120K with participation from PPP
Series A (2024): $13M led by Sorenson, Hackensack Meridian Health, and Cortes Capital
Key Investors in Canary Speech
Sorenson
Sorenson is a global leader in language services and accessible communication, leveraging patented technology to bridge signed and spoken languages for the Deaf and hard-of-hearing community.
Hackensack Meridian Health
A prominent not-for-profit health care network in New Jersey, providing comprehensive medical services, innovative research, and integrated patient care solutions.
Cortes Capital
Cortes Capital is a diversified investment firm providing property management, financing, and strategic advisory services to support long-term growth and market resilience.
What's next for Canary Speech?
With this recent capital injection, Canary Speech is poised to accelerate its expansion into broader clinical and pharmaceutical markets. The strategic focus will likely center on scaling its AI infrastructure to support high-volume telemedicine deployments and deepening its research partnerships to validate speech biomarkers for chronic disease management. As the healthcare industry continues to prioritize remote diagnostics, Canary Speech is well-positioned to capitalize on the demand for objective, data-driven patient monitoring solutions. Future growth will be defined by the company's ability to integrate its vocal analysis engine into existing electronic health record systems and expand its footprint within global health networks.
See full Canary Speech company page
